Public Profile

Meitheal

Meitheal Pharmaceuticals, often referred to simply as Meitheal, is a prominent player in the pharmaceutical industry, headquartered in the United States. Founded in 2015, the company has rapidly established itself in the global market, focusing on the development and manufacturing of high-quality generic and specialty pharmaceuticals. With a strong operational presence in North America and Europe, Meitheal is dedicated to providing innovative solutions that meet the evolving needs of healthcare providers and patients. Their core offerings include a diverse range of injectable and oral dosage forms, distinguished by their commitment to quality and compliance with stringent regulatory standards. Recognised for its rapid growth and strategic partnerships, Meitheal Pharmaceuticals continues to enhance its market position, striving to deliver accessible healthcare solutions while maintaining a focus on patient safety and efficacy.

DitchCarbon Score

How does Meitheal's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

3

Industry Average

Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

8

Industry Benchmark

Meitheal's score of 3 is lower than 81% of the industry. This can give you a sense of how well the company is doing compared to its peers.

19%

Meitheal's reported carbon emissions

Meitheal currently does not have available carbon emissions data, as no specific figures have been provided. Consequently, there are no reported emissions in terms of Scope 1, 2, or 3. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. In the absence of concrete data, it is essential to note that many companies in the industry are increasingly committing to ambitious climate goals, often aligning with global standards such as the Science Based Targets initiative (SBTi). Meitheal may be exploring similar pathways to enhance their sustainability efforts and reduce their carbon footprint in the future.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Meitheal's primary industry is Research and development services (73), which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Meitheal is headquartered in US, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Meitheal is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Other Organizations in Research Services

Acuris

GB
Research Services
Updated 11 days ago

Future Fluent

US
Research Services
Updated 11 days ago

Quanticate

GB
Research Services
Updated 11 days ago

Snow Companies

US
Research Services
Updated 10 days ago
CDP

Diamond Wipes

US
Research Services
Updated 11 days ago

Sichuan KELUN PHARMACEUTICAL Co., Ltd.

CN
Research Services
Updated 8 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers